Sage Therapeutics fires 40% of staff after FDA rejected MDD bid
The company announced a strategic shake-up that includes layoffs, leadership changes and halting of early-stage programs.
The company announced a strategic shake-up that includes layoffs, leadership changes and halting of early-stage programs.
What's Your Reaction?
